294 related articles for article (PubMed ID: 31749052)
1. One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study.
Borrelli E; Parravano M; Querques L; Sacconi R; Giorno P; De Geronimo D; Bandello F; Querques G
Acta Diabetol; 2020 May; 57(5):543-548. PubMed ID: 31749052
[TBL] [Abstract][Full Text] [Related]
2. Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study.
Querques L; Parravano M; Sacconi R; Rabiolo A; Bandello F; Querques G
Acta Diabetol; 2017 Aug; 54(8):769-773. PubMed ID: 28577137
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
4. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
Zur D; Iglicki M; Sala-Puigdollers A; Chhablani J; Lupidi M; Fraser-Bell S; Mendes TS; Chaikitmongkol V; Cebeci Z; Dollberg D; Busch C; Invernizzi A; Habot-Wilner Z; Loewenstein A;
Acta Ophthalmol; 2020 Mar; 98(2):e217-e223. PubMed ID: 31421028
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
[TBL] [Abstract][Full Text] [Related]
6. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
[TBL] [Abstract][Full Text] [Related]
8. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
[TBL] [Abstract][Full Text] [Related]
9. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone implant in diabetic macular edema in real-life situations.
Chhablani J; Bansal P; Veritti D; Sambhana S; Sarao V; Pichi F; Carrai P; Massaro D; Lembo A; Mansour AM; Banker A; Gupta SR; Hamam R; Lanzetta P
Eye (Lond); 2016 Mar; 30(3):426-30. PubMed ID: 26611849
[TBL] [Abstract][Full Text] [Related]
12. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
Esen E; Sizmaz S; Demircan N
Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412
[TBL] [Abstract][Full Text] [Related]
14. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
Lo Giudice G; Avarello A; Campana G; Galan A
Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
[TBL] [Abstract][Full Text] [Related]
15. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
[TBL] [Abstract][Full Text] [Related]
16. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
Iacono P; Parodi MB; Scaramuzzi M; Bandello F
Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
[TBL] [Abstract][Full Text] [Related]
17. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.
Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F
Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
Mahapatra SK; Kumari S
Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.
Kim M; Cho YJ; Lee CH; Lee SC
Eye (Lond); 2016 May; 30(5):718-25. PubMed ID: 26939558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]